Advances in Chronic Kidney Disease
Volume 14, Issue 4 , Pages 319-327 , October 2007

Symptoms and Their Correlates in Chronic Kidney Disease

  • Steven D. Weisbord

      Affiliations

    • Renal Section, Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, PA
    • Department of Medicine, Renal-Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, PA.
    • Corresponding Author InformationAddress correspondence to Steven Weisbord, VA Pittsburgh Healthcare System, Mailstop 111F-U, 7E Room 120, Pittsburgh, PA 15240.

References 

  1. Evans RW, Manninen DL, Garrison LP, et al. The quality of life of patients with end-stage renal disease. N Engl J Med. 1985;312:553–559
  2. Johnson JP, McCauley CR, Copley JB. The quality of life of hemodialysis and transplant patients. Kidney Int. 1982;22:286–291
  3. Kimmel PL, Peterson RA, Weihs KL, et al. Aspects of quality of life in hemodialysis patients. J Am Soc Nephrol. 1995;6:1418–1426
  4. Kimmel PL. Psychosocial factors in adult end-stage renal disease patients treated with hemodialysis: Correlates and outcomes. Am J Kidney Dis. 2000;35:S132–S140
  5. Kimmel PL, Patel SS. Quality of life in patients with chronic kidney disease: Focus on end-stage renal disease treated with hemodialysis. Semin Nephrol. 2006;26:68–79
  6. Kimmel PL, Peterson RA, Weihs KL, et al. Psychosocial factors, behavioral compliance and survival in urban hemodialysis patients. Kidney Int. 1998;54:245–254
  7. Kimmel PL, Peterson RA, Weihs KL, et al. Psychologic functioning, quality of life, and behavioral compliance in patients beginning hemodialysis. J Am Soc Nephrol. 1996;7:2152–2159
  8. Unruh ML, Weisbord SD, Kimmel PL. Health-related quality of life in nephrology research and clinical practice. Semin Dial. 2005;18:82–90
  9. Barrett BJ, Vavasour HM, Major A, et al. Clinical and psychological correlates of somatic symptoms in patients on dialysis. Nephron. 1990;55:10–15
  10. Davison SN. Pain in hemodialysis patients: Prevalence, cause, severity, and management. Am J Kidney Dis. 2003;42:1239–1247
  11. Davison SN, Jhangri GS. The impact of chronic pain on depression, sleep, and the desire to withdraw from dialysis in hemodialysis patients. J Pain Symptom Manage. 2005;30:465–473
  12. Davison SN, Jhangri GS, Johnson JA. Cross-sectional validity of a modified Edmonton symptom assessment system in dialysis patients: A simple assessment of symptom burden. Kidney Int. 2006;69:1621–1625
  13. Merkus MP, Jager KJ, Dekker FW, et al. Physical symptoms and quality of life in patients on chronic dialysis: Results of The Netherlands Cooperative Study on Adequacy of Dialysis (NECOSAD). Nephrol Dial Transplant. 1999;14:1163–1170
  14. Parfrey PS, Vavasour H, Bullock M, et al. Symptoms in end-stage renal disease: Dialysis v transplantation. Transplant Proc. 1987;19:3407–3409
  15. Parfrey PS, Vavasour H, Bullock M, et al. Development of a health questionnaire specific for end-stage renal disease. Nephron. 1989;52:20–28
  16. Parfrey PS, Vavasour HM, Henry S, et al. Clinical features and severity of nonspecific symptoms in dialysis patients. Nephron. 1988;50:121–128
  17. Weisbord SD, Bruns FJ, Rotondi AJ, et al. Symptom burden, quality-of-life and advance care planning in highly comorbid hemodialysis patients: Is there a role for palliative care?. Nephrol Dial Transplant. 2003;18:1345–1352
  18. Weisbord SD, Fried LF, Arnold RM, et al. Development of a symptom assessment instrument for chronic hemodialysis patients: The Dialysis Symptom Index. J Pain Symptom Manage. 2004;27:226–240
  19. Weisbord SD, Fried LF, Arnold RM, et al. Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients. J Am Soc Nephrol. 2005;16:2487–2494
  20. Kimmel PL, Emont SL, Newmann JM, et al. ESRD patient quality of life: Symptoms, spiritual beliefs, psychosocial factors, and ethnicity. Am J Kidney Dis. 2003;42:713–721
  21. Wu AW, Fink NE, Cagney KA, et al. Developing a health-related quality-of-life measure for end-stage renal disease: The CHOICE Health Experience Questionnaire. Am J Kidney Dis. 2001;37:11–21
  22. Kimmel PL. Just whose quality of life is it anyway? (Controversies and consistencies in measurements of quality of life). Kidney Int. 2000;57:S113–S120
  23. Edgell ET, Coons SJ, Carter WB, et al. A review of health-related quality-of-life measures used in end-stage renal disease. Clin Ther. 1996;18:887–938
  24. Hays RD, Kallich JD, Mapes DL, et al. Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res. 1994;3:329–338
  25. Evans RW, Rader B, Manninen DL. The quality of life of hemodialysis recipients treated with recombinant human erythropoietin (Cooperative Multicenter EPO Clinical Trial Group). JAMA. 1990;263:825–830
  26. Furuland H, Linde T, Ahlmen J, et al. A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients. Nephrol Dial Transplant. 2003;18:353–361
  27. Levin NW, Lazarus JM, Nissenson AR. National Cooperative rHu Erythropoietin Study in patients with chronic renal failure—An interim report (The National Cooperative rHu Erythropoietin Study Group). Am J Kidney Dis. 1993;22:3–12
  28. Davison SN, Jhangri GS, Johnson JA. Longitudinal validation of a modified Edmonton symptom assessment system (ESAS) in haemodialysis patients. Nephrol Dial Transplant. 2006;21:3189–3195
  29. Binik YM, Baker AG, Kalogeropoulos D, et al. Pain, control over treatment, and compliance in dialysis and transplant patients. Kidney Int. 1982;21:840–848
  30. Barakzoy AS, Moss AH. Efficacy of the world health organization analgesic ladder to treat pain in end-stage renal disease. J Am Soc Nephrol. 2006;17:3198–3203
  31. Rosas SE, Joffe M, Franklin E, et al. Prevalence and determinants of erectile dysfunction in hemodialysis patients. Kidney Int. 2001;59:2259–2266
  32. Seibel I, Poli De Figueiredo CE, Teloken C, et al. Efficacy of oral sildenafil in hemodialysis patients with erectile dysfunction. J Am Soc Nephrol. 2002;13:2770–2775
  33. Hyodo T, Ishida H, Masui N, et al. Kidney disease quality of life of Japanese dialysis patients who desire administration of sildenafil and the treatment of erectile dysfunction using sildenafil. Ther Apher Dial. 2004;8:340–346
  34. Kimmel PL. Go to bed and get a good night’s sleep: You need your rest!. Am J Kidney Dis. 2000;35:1221–1223
  35. Unruh ML, Hartunian MG, Chapman MM, et al. Sleep quality and clinical correlates in patients on maintenance dialysis. Clin Nephrol. 2003;59:280–288
  36. Shayamsunder AK, Patel SS, Jain V, et al. Sleepiness, sleeplessness, and pain in end-stage renal disease: Distressing symptoms for patients. Semin Dial. 2005;18:109–118
  37. Millman RP, Kimmel PL, Shore ET, et al. Sleep apnea in hemodialysis patients: The lack of testosterone effect on its pathogenesis. Nephron. 1985;40:407–410
  38. Walker S, Fine A, Kryger MH. Sleep complaints are common in a dialysis unit. Am J Kidney Dis. 1995;26:751–756
  39. Parker KP, Kutner NG, Bliwise DL, et al. Nocturnal sleep, daytime sleepiness, and quality of life in stable patients on hemodialysis. Health Qual Life Outcomes. 2003;1:68
  40. Iliescu EA, Coo H, McMurray MH, et al. Quality of sleep and health-related quality of life in haemodialysis patients. Nephrol Dial Transplant. 2003;18:126–132
  41. Shayamsunder AK, Khetpal P, Patel SS, et al. Sleep disturbance, pain and quality of life in hemodialysis patients. J Am Soc Nephrol. 2004;15:636A;(abstr)
  42. Zoccali C, Mallamaci F, Tripepi G. Nocturnal hypoxemia predicts incident cardiovascular complications in dialysis patients. J Am Soc Nephrol. 2002;13:729–733
  43. Zeigler M. Sleep disorders and the failure to lower nocturnal blood pressure. Curr Opin Nephrol Hypertens. 2003;12:97–102
  44. Jung HH, Han H, Lee JH. Sleep apnea, coronary artery disease, and antioxidant status in hemodialysis patients. Am J Kidney Dis. 2005;45:875–882
  45. Sivertsen B, Omvik S, Pallesen S, et al. Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial. JAMA. 2006;295:2851–2858
  46. Pressman MR, Benz RL, Schleifer CR, et al. Sleep disordered breathing in ESRD: Acute beneficial effects of treatment with nasal continuous positive airway pressure. Kidney Int. 1993;43:1134–1139
  47. Janzen L, Rich JA, Vercaigne LM. An overview of levodopa in the management of restless legs syndrome in a dialysis population: Pharmacokinetics, clinical trials, and complications of therapy. Ann Pharmacother. 1999;33:86–92
  48. Juergense PH, Botev R, Wuerth D, et al. Erectile dysfunction in chronic peritoneal dialysis patients: Incidence and treatment with sildenafil. Perit Dial Int. 2001;21:355–359
  49. Turk S, Karalezli G, Tonbul HZ, et al. Erectile dysfunction and the effects of sildenafil treatment in patients on haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 2001;16:1818–1822
  50. Rocco MV, Gassman JJ, Wang SR, et al. Cross-sectional study of quality of life and symptoms in chronic renal disease patients: The Modification of Diet in Renal Disease Study. Am J Kidney Dis. 1997;29:888–896
  51. Saini T, Murtagh FE, Dupont PJ, et al. Comparative pilot study of symptoms and quality of life in cancer patients and patients with end stage renal disease. Palliat Med. 2006;20:631–636

PII: S1548-5595(07)00091-2

doi: 10.1053/j.ackd.2007.07.004

Advances in Chronic Kidney Disease
Volume 14, Issue 4 , Pages 319-327 , October 2007

Article Tools

* Image Usage & Resolution